Fatal thrombotic microangiopathy case following adeno-associated viral SMN gene therapy

被引:82
|
作者
Guillou, Julia [1 ]
de Pellegars, Alice [2 ]
Porcheret, Florence [1 ]
Fremeaux-Bacchi, Veronique [3 ]
Allain-Launay, Emma [1 ]
Debord, Camille [4 ]
Denis, Manon [5 ,6 ]
Pereon, Yann [7 ]
Barnerias, Christine [8 ]
Desguerre, Isabelle [8 ]
Roussey, Gwenaelle [1 ]
Mercier, Sandra [6 ,9 ]
机构
[1] Univ CHU Nantes, Ctr Hosp, Nantes, France
[2] CHU Angers, Federat Pediatrie, Angers, France
[3] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Serv dImmunol, Paris, France
[4] CHU Nantes, Lab Dhematol, Nantes, France
[5] CHU Nantes, Paediat Intens Care Unit, Nantes, France
[6] Univ Nantes, Ctr Natl La Rech Sci CNRS, Inst Natl La Sante & La Rech Med INSERM, Inst Thorax, Nantes, France
[7] CHU Nantes, Univ Hosp,Filnemus,Euro NMD, Reference Ctr Neuromuscular Disorders, Atlantique Occitanie Carathes AOC, Nantes, France
[8] Necker Enfants Malad Hosp, Reference Ctr Neuromuscular Disorders Filnemus Eu, Assistance Publ Hop Paris APHP, Paris, France
[9] CHU Nantes, Ctr Reference Malad Neuromusculaires AOC, Serv Genet Med, Nantes, France
关键词
HEMOLYTIC-UREMIC SYNDROME; SPINAL MUSCULAR-ATROPHY; ONASEMNOGENE ABEPARVOVEC; SOLUBLE C5B-9; CFI GENE; BIOMARKER; VARIANTS; ONSET;
D O I
10.1182/bloodadvances.2021006419
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adeno-associated virus (AAV) gene therapies are highly promising, such as the onasemnogene abeparvovec (Zolgensma) in spinal muscle atrophy (SMA). We report the first case of fatal systemic thrombotic microangiopathy (TMA) following onasemnogene abeparvovec in a 6-month-old child with SMA type 1, carrying a potential genetic predisposition in the complement factor I gene. Other cases of TMA have recently been reported after onasemnogene abeparvovec and after AAV9 minidystrophin therapy in Duchenne muscular dystrophy. The risk-benefit ratio of this therapy must therefore be assessed. Early recognition of TMA and targeted immunotherapy are fundamental to ensure the safety of patients treated with AAV gene therapies.
引用
收藏
页码:4266 / 4270
页数:5
相关论文
共 50 条
  • [11] Adeno-Associated Viral Gene Therapy for Inherited Retinal Disease
    Tuyen Ong
    Mark E. Pennesi
    David G. Birch
    Byron L. Lam
    Stephen H. Tsang
    Pharmaceutical Research, 2019, 36
  • [12] Adeno-associated viral gene therapy for propionic acidemia (PA)
    Chandler, R. J.
    Smith, S. N.
    Venditti, C. V.
    HUMAN GENE THERAPY, 2019, 30 (11) : A149 - A150
  • [13] Adeno-associated viral gene therapy for mucopolysaccharidoses exhibiting neurodegeneration
    Adeline A. Lau
    Kim M. Hemsley
    Journal of Molecular Medicine, 2017, 95 : 1043 - 1052
  • [14] Novel adeno-associated viral vectors for retinal gene therapy
    L H Vandenberghe
    A Auricchio
    Gene Therapy, 2012, 19 : 162 - 168
  • [15] A humanized mouse model for adeno-associated viral gene therapy
    Mercedes Barzi
    Tong Chen
    Trevor J. Gonzalez
    Francis P. Pankowicz
    Seh Hoon Oh
    Helen L. Streff
    Alan Rosales
    Yunhan Ma
    Sabrina Collias
    Sarah E. Woodfield
    Anna Mae Diehl
    Sanjeev A. Vasudevan
    Thao N. Galvan
    John Goss
    Charles A. Gersbach
    Beatrice Bissig-Choisat
    Aravind Asokan
    Karl-Dimiter Bissig
    Nature Communications, 15
  • [16] Progress in the use of adeno-associated viral vectors for gene therapy
    Büning, H
    Braun-Falco, M
    Hallek, M
    CELLS TISSUES ORGANS, 2004, 177 (03) : 139 - 150
  • [17] Gene Therapy for Choroideremia Using an Adeno-Associated Viral (AAV) Vector
    Barnard, Alun R.
    Groppe, Markus
    MacLaren, Robert E.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2015, 5 (03):
  • [18] Progress in Bioengineering of Myotropic Adeno-Associated Viral Gene Therapy Vectors
    Liu, Jixin
    Koay, Teng Wei
    Maiakovska, Olena
    Zayas, Margarita
    Grimm, Dirk
    HUMAN GENE THERAPY, 2023, 34 (9-10) : 350 - 364
  • [19] Adeno-associated viral vector gene therapy: Challenges for the paediatric hepatologist
    Jagadisan, Barath
    Dhawan, Anil
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2024, 79 (03): : 485 - 494
  • [20] Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy
    Jooss, K
    Chirmule, N
    GENE THERAPY, 2003, 10 (11) : 955 - 963